Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
TMEM184C divergent transcript (TMEM184C-DT, loc105377478) is a predicted long noncoding RNA (lncRNA) gene located in close proximity to the TMEM184C protein-coding locus. Divergent transcripts are defined as lncRNAs oriented head-to-head and within 300–500 nucleotides of an annotated protein-coding gene[4]. There is currently no evidence for this transcript encoding a functional protein, serving as a therapeutic target, or being implicated in human disease processes. Its function, disease relevance, and druggability are uncharacterized. Its nomenclature reflects its genomic context rather than known biological or pharmacological function.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on TMEM184C divergent transcript (TMEM184C-DT).